Vakzine

Vakzine are biological preparations that train the immune system to recognize and fight specific infectious diseases. They usually introduce harmless components of a pathogen, such as inactivated organisms, proteins, or genetic material, prompting an immune response without causing disease.

Common vaccine types include inactivated, live-attenuated, toxoid, subunit or conjugate vaccines, and newer platforms such as mRNA and viral-vector vaccines. Each type presents antigens to the immune system in a manner that balances safety and effectiveness.

Vaccines aim to induce adaptive immunity, producing antibodies and memory cells that respond rapidly upon real exposure. Some vaccines primarily stimulate antibody responses, while others also elicit T-cell–mediated protection. Booster doses may be required to sustain immunity.

Development follows preclinical testing and phased clinical trials to assess safety and efficacy. Regulatory authorities evaluate data before approval and require post-marketing pharmacovigilance. Vaccines are implemented through immunization programs guided by public health authorities and national schedules.

The concept of vaccination traces to Edward Jenner's smallpox work in the late 18th century, expanding through a century of advances in virology and immunology. Vaccination has reduced disease burden, prevented outbreaks, and, in some cases, led to eradication. Practical aspects include cold-chain storage and monitoring for adverse events.